Literature DB >> 7294082

Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue.

O Jänne, A Kauppila, E Kokko, T Lantto, L Rönnberg, R Vihko.   

Abstract

Cytosol estrogen (ER) and progestin (PR) receptors were quantified in 47 endometriosis lesions from 41 patients and compared with receptor measurements in the endometrial tissue of nine of these patients. Half of the specimens of endometriosis tissue contained PR only, in concentrations that were significantly lower than in the endometrium. Only 30% of the specimens of endometriosis tissue contained the two receptors simultaneously, and levels of ER were very low compared with those in the endometrium. Levels of PR in the specimens of endometriosis tissue were highest at the periovulatory period, whereas concentrations of ER tended to be highest at the beginning and close to the end of the cycle. These results suggest that regulation of these receptors is dissimilar in endometriosis lesions and endometrium. It remains to be seen whether differences in receptor distribution in the lesions of individual patients could explain differences in the course of this disease, and have therapeutic implications. The presence of PR in the majority of the endometriosis lesions is in accord with the favorable therapeutic response often obtained with progestin treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7294082     DOI: 10.1016/s0002-9378(15)33278-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Relationship between 17-beta-estradiol and prolactin in the regulation of natural killer cell activity during progression of endometriosis.

Authors:  M Provinciali; G Di Stefano; M Muzzioli; G G Garzetti; A Ciavattini; N Fabris
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Immunohistochemical detection of estrogen and progesterone receptors in endometriotic tissue. A comparative study of paraffin embedded and fresh frozen tissues.

Authors:  P A Regidor; M Regidor; K A Metz; A E Schindler
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

3.  Pleural endometriosis: an exceptional cause of hemorrhagic pleural effusion.

Authors:  Soumya Bhattacharjee; Jaydip Deb; Rama Saha; Sudipta Chakrabarti; Joydev Mukherji; Sumit Roy Tapadar
Journal:  J Obstet Gynaecol India       Date:  2013-02-22

Review 4.  Endometriosis 1990. Current treatment approaches.

Authors:  R L Barbieri
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 5.  Epidemiology of endometriosis.

Authors:  P Mangtani; M Booth
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

6.  The pathology of endometriosis.

Authors:  H Fox
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

7.  LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation.

Authors:  U Cirkel; K W Schweppe; H Ochs; J P Hanker; H P Schneider
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

8.  A cross-study gene set enrichment analysis identifies critical pathways in endometriosis.

Authors:  Hongbo Zhao; Qishan Wang; Chunyan Bai; Kan He; Yuchun Pan
Journal:  Reprod Biol Endocrinol       Date:  2009-09-08       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.